In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Patients taking azathioprine or 6-mercaptopurine for inflammatory bowel disease (IBD) have more than a five-times higher risk of developing a lymphoproliferative disorder compared…
NEW YORK (Reuters Health) – Prophylactic use of acetaminophen during vaccination in children can reduce febrile reactions, but unfortunately the antibody responses to various vaccine antigens are weakened,…
NEW YORK (Reuters Health) – Both low and high levels of adiponectin are associated with an increased risk of death in patients with type 2 diabetes, according to…
NEW YORK (Reuters Health) – Pain from cluster headaches is substantially relieved within half an hour after dosing with 5 to 10 mg of zolmitriptan nasal spray, according…
NEW YORK (Reuters Health) – Whether the catheter is removed or not has no bearing on the resolution of catheter-related coagulase-negative staphylococcal bacteremia following treatment with antimicrobial therapy,…
NEW YORK (Reuters Health) – Percutaneous intervention may not be necessary for the majority of hypertensive patients with atherosclerotic renovascular disease. In a large retrospective study, researchers from…
NEW YORK (Reuters Health) – For patients with a hematocrit nadir of 24%-30% following percutaneous coronary intervention (PCI), the benefits of blood transfusion are unlikely to outweigh the…
The American College of Physicians (ACP) has issued recommendations for the treatment of erectile dysfunction (ED). ACP strongly recommends that physicians initiate therapy with an oral phosphodiesterase type…
NEW YORK (Reuters Health) – The results of a systematic review suggest that use of an ACE inhibitor reduces total mortality and the risk of nonfatal MI in…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
